About QuantHealth
QuantHealth is a clinical AI company that has developed a next-generation platform for simulating clinical trial outcomes before they are conducted. The company's proprietary technology combines a comprehensive biomedical knowledge graph with real-world data from over 350 million patient lives to create digital twins and digital drugs that can predict how any patient will respond to any therapy. QuantHealth's platform supports pharmaceutical sponsors across the entire clinical development lifecycle, from early protocol optimization and indication selection to business development and portfolio management. The company's AI models have demonstrated 85% accuracy in predicting primary endpoints prospectively, without requiring sponsor data. By simulating thousands of protocol variations in parallel, QuantHealth enables sponsors to optimize trial design, reduce enrollment time, minimize patient numbers, and improve probability of technical success. The platform integrates multi-modal data including biomedical knowledge, clinical trial results, and epidemiological information, with over 10,000 data points per patient spanning more than 10 years of medical history. QuantHealth serves pharmaceutical companies across multiple therapeutic areas including oncology, respiratory disease, metabolic disorders, and inflammatory conditions, helping them make data-driven decisions that reduce costs and accelerate time to market.
Clinical Focus
Medical conditions and clinical areas addressed by QuantHealth.
Who It Serves
Milestones & Awards
Recent Milestones
Over 350 trials simulated, 85% endpoint prediction accuracy achieved, multiple case studies published demonstrating value across therapeutic areas (2023-2024)
Company Details
- Headquarters
- Worcester, MA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.